Merck & Co Inc (NYSE:MRK)
| 111.05 Delayed Data As of May 26 |  -1.25 / -1.11%Today’s Change | 83.05 Today|||52-Week Range 119.65 | +0.09% Year-to-Date |
Latest MRK News | Press Releases
| Pfizer's (PFE) COVID-19 Oral Treatment Gets FDA Nod in Adults May 26 / Zacks.com - Paid Partner Content | Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? May 22 / Zacks.com - Paid Partner Content |
| PDS Biotech (PDSB) Up 32% on Interim Data From HPV Cancer Study May 26 / Zacks.com - Paid Partner Content | PDS Biotech (PDSB) Completes Enrollment for HPV Cancer Study May 19 / Zacks.com - Paid Partner Content |
| Immutep (IMMP) Up on Initial Data From Lung Cancer Study May 25 / Zacks.com - Paid Partner Content | Immutep (IMMP) Surges 65% on Upbeat Lung Cancer Study Data May 18 / Zacks.com - Paid Partner Content |
| Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know May 25 / Zacks.com - Paid Partner Content | Here's Why Merck (MRK) Stock Has Outperformed Industry YTD May 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 112.30 |
| Today’s open | 112.00 |
| Day’s range | 110.67 - 113.19 |
| Volume | 6,378,339 |
| Average volume (3 months) | 7,632,311 |
| Market cap | $293.0B |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +11.18% |
| Earnings growth (this year) | -6.75% |
| Earnings growth (next 5 years) | +8.80% |
| Revenue growth (last year) | +19.56% |
| P/E ratio | 21.7 |
| Price/Sales | 4.82 |
| Price/Book | 6.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +0.57 | +0.35% |
| ABBVAbbVie | -1.02 | -0.74% |
| AZNAstraZeneca | +0.72 | +1.00% |
| PFEPfizer | -0.23 | -0.61% |
Data as of 4:00pm ET, 05/26/2023
Financials
| Next reporting date | August 1, 2023 |
| EPS forecast (this quarter) | $1.85 |
| Annual revenue (last year) | $58.5B |
| Annual profit (last year) | $14.5B |
| Net profit margin | 24.83% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
